1.1 Introduction
Gestational diabetes is a medical condition defined as glucose intolerance of varying severity that is first recognized during pregnancy (American Diabetes Association, 2022). It is a significant health concern because it affects both the mother and the developing fetus, with potential short-term and long-term complications. Women with gestational diabetes are at increased risk of hypertensive disorders, preeclampsia, and cesarean delivery, while their neonates are predisposed to macrosomia, birth trauma, neonatal hypoglycemia, and a higher likelihood of developing metabolic disorders later in life (Moses et al., 2020; Catalano, 2021).
The prevalence of gestational diabetes is rising globally, with variations across regions due to differences in genetics, lifestyle, and healthcare access (Hod et al., 2019). In Nigeria, studies indicate that the condition is underdiagnosed and often poorly managed, especially in resource-limited settings where specialized monitoring and timely interventions are scarce (Ogu et al., 2018).
As a prelude to other parts of this study, this chapter will discuss the background upon which this study was initiated, the statement of problems that led to this study, the Aim and Objectives of the study. Others are significance of the study, scope of work, research hypothesis and questions, limitation of the study and definition of terms.
1.2 Background of Study
Gestational diabetes is a medical condition characterized by elevated blood glucose levels that develop during pregnancy, affecting women who previously had normal glucose tolerance. According to the American Diabetes Association (2022), gestational diabetes is associated with significant maternal and neonatal complications, making its evaluation critical in improving pregnancy outcomes. Moses et al. (2020) reported that women with gestational diabetes are at higher risk of developing preeclampsia, hypertensive disorders, and the need for cesarean delivery, while their neonates are predisposed to macrosomia, birth injuries, hypoglycemia, and long-term metabolic disorders (Moses et al., 2020).
Studies conducted globally have affirmed that the prevalence of gestational diabetes is rising, with variations based on genetic, dietary, and environmental factors. Catalano (2021) asserted that maternal obesity, advanced maternal age, and family history of diabetes are key risk factors that increase the likelihood of gestational diabetes, which in turn affects neonatal health. Hod et al. (2019) contended that early diagnosis and proper management, including blood glucose monitoring, dietary adjustments, and sometimes pharmacological intervention, are essential in minimizing adverse outcomes. However, they reported that implementation of these measures is often inconsistent in resource-limited settings, where access to specialized care and continuous monitoring is limited (Hod et al., 2019).
In the Nigerian context, Ogu et al. (2018) stated that gestational diabetes is underdiagnosed and poorly managed in many hospitals, resulting in preventable maternal and neonatal complications. Khalafallah et al. (2018) affirmed that the psychological burden of the condition, including stress and anxiety in affected mothers, further complicates adherence to treatment protocols, impacting both maternal and neonatal well-being. On the other hand, healthcare providers face challenges in standardizing care due to variations in patient awareness, cultural perceptions about pregnancy, and limited resources, which exacerbate the risk of adverse outcomes. This study is set against the backdrop of evaluating gestational diabetes as a medical condition in women and neonates at Jos University Teaching Hospital.
1.3 Statement of Problems
Investigation revealed that gestational diabetes is a medical condition that is increasingly recognized as a significant health concern for both pregnant women and their neonates. It is characterized by elevated blood glucose levels that develop during pregnancy, often leading to complications such as preeclampsia, preterm birth, and increased risk of cesarean delivery (American Diabetes Association, 2022).
For neonates, gestational diabetes is associated with higher incidences of macrosomia, neonatal hypoglycemia, and long-term metabolic disorders, which is a growing concern in maternal and child health (Moses et al., 2020). On the other hand, healthcare providers often face challenges in implementing standardized guidelines due to varying patient responses, limited educational resources, and cultural perceptions about pregnancy and diet, which is increasingly affecting the quality of care provided.
Furthermore, gestational diabetes is sometimes underdiagnosed because of the subtle nature of its symptoms, and many women do not receive timely intervention. This delay in diagnosis is associated with increased risks of both maternal and neonatal complications, including long-term predisposition to type 2 diabetes in mothers and metabolic disorders in children (Catalano, 2021). The psychological impact on mothers, who often experience anxiety and stress related to the condition, is also notable, influencing both maternal well-being and adherence to treatment protocols (Khalafallah et al., 2018). It is against this backdrop that this study seeks to evaluate gestational diabetes as a medical condition in women and neonates, using Jos University Teaching Hospital as a case study.
1.4 Aim and Objectives of Study
The aim of the study is to evaluate gestational diabetes as a medical condition in women and neonates at Jos University Teaching Hospital and assess its impact on maternal and neonatal health.
To achieve this aim, the study has the following objectives:
- To determine the prevalence of gestational diabetes among pregnant women attending Jos University Teaching Hospital.
- To identify the maternal risk factors associated with gestational diabetes.
- To examine the management practices and interventions provided to women diagnosed with gestational diabetes.
- To assess the maternal and neonatal outcomes associated with gestational diabetes.
- To provide recommendations for improving the screening, diagnosis, and management of gestational diabetes at Jos University Teaching Hospital.
1.5 Research Questions
The study came up with research questions so as to be able to ascertain the above stated objectives. The specific research questions for the study are stated below as follows:
- What is the prevalence of gestational diabetes among pregnant women at Jos University Teaching Hospital?
- What maternal factors are associated with the development of gestational diabetes in women attending the hospital?
- How is gestational diabetes managed and treated among patients at Jos University Teaching Hospital?
- What are the maternal and neonatal outcomes of gestational diabetes at the hospital?
- What measures can be implemented to improve the detection and management of gestational diabetes in this setting?
1.6 Research Hypothesis
In order to pursue the objective of this study, the following generalized statements have been designed to guide and aids in obtaining the result for the experiment to be conducted. For this work, the null hypothesis will be represented with H0 while the alternative hypothesis will be represented with hypothesis H1.
- H0: There is no significant relationship between maternal risk factors and the occurrence of gestational diabetes among women attending Jos University Teaching Hospital.
- H1: There is a significant relationship between maternal risk factors and the occurrence of gestational diabetes among women attending Jos University Teaching Hospital.
1.7 Significance of Study
It is believed that at the completion of the study, the findings will improve awareness among healthcare providers and patients about the risks and implications of gestational diabetes. Also, pregnant women will benefit from increased awareness and education about the risks, prevention, and management of gestational diabetes.
Furthermore, hospital administrators will receive data that will support the development of standardized protocols and resource allocation for maternal and neonatal care. In addition, the outcome of this research will benefit pregnant women by increasing awareness of gestational diabetes and its implications on maternal and neonatal health.
Lastly, the research will serve as a reference for policymakers in developing strategies to strengthen maternal and neonatal care. The study will also contribute to academic literature and future research in maternal and neonatal health within Nigeria.
1.8 Scope of Study
The study focuses on evaluating gestational diabetes in women and neonates attending Jos University Teaching Hospital in Plateau State, Nigeria. The study covers women attending antenatal care and delivery services over a defined period, providing a comprehensive overview of gestational diabetes within the hospital context.
1.9 Limitations of the Study
During the course of this study, there were some problems encountered which stood as limitations to the research work. Some of the limitations include:
- Time Constraint: The time frame given to accomplish this project was very short due to school academic calendar and it was carried out under pressure which made the researcher not to implement some necessary features.
- Financial Constraint: Insufficient fund tends to impede the efficiency of the researcher in sourcing for the relevant materials, literature or information and in the process of data collection (internet, questionnaire and interview).
- Initial Cooperation Delay from Respondents: A particular limitation of this work came as a result of the respondent refusal to offer their cooperation at the initial time they were contacted. This contributed in making the success of this research study difficult.
1.10 Definition of Terms
Gestational Diabetes: A form of glucose intolerance first recognized during pregnancy, associated with maternal and neonatal complications (American Diabetes Association, 2022).
Neonates: Infants in the first 28 days of life (World Health Organization, 2013).
Maternal Outcomes: Health consequences experienced by women during pregnancy and postpartum as a result of gestational diabetes (Catalano, 2021).
Neonatal Outcomes: Health conditions in newborns associated with maternal gestational diabetes, including birth weight anomalies, hypoglycemia, and long-term metabolic risks (Moses et al., 2020).
Screening: Medical evaluation of pregnant women to detect gestational diabetes through blood glucose tests and risk assessment (Hod et al., 2019).
Management Practices: Interventions including diet, lifestyle modifications, blood glucose monitoring, and pharmacological treatment applied to control gestational diabetes in pregnant women (Khalafallah et al., 2018).
…